Skip to main content
. 2017 Mar 3;5(2):53–58. doi: 10.1016/j.prnil.2017.02.002

Fig. 4.

Fig. 4

Biochemical recurrence-free survival curve stratified by period until prostate-specific antigen (PSA) nadir (3 months interval) in high risk patients by cancer of the prostate risk assessment (CAPRA) risk stratification among patients with positive surgical margin.